litlas
Log inCreate account

Robert D. Schreiber

Active 1974–2024

208
Papers
104,458
Citations
133
h-index
207
i10-index

Citations

Citations per year for Robert D. Schreiber1905: 2 citations1945: 1 citations1975: 5 citations1976: 14 citations1977: 17 citations1978: 17 citations1979: 14 citations1980: 33 citations1981: 23 citations1982: 28 citations1983: 50 citations1984: 64 citations1985: 77 citations1986: 69 citations1987: 93 citations1988: 93 citations1989: 70 citations1990: 74 citations1991: 123 citations1992: 183 citations1993: 262 citations1994: 291 citations1995: 390 citations1996: 526 citations1997: 548 citations1998: 655 citations1999: 643 citations2000: 660 citations2001: 703 citations2002: 803 citations2003: 735 citations2004: 775 citations2005: 778 citations2006: 799 citations2007: 695 citations2008: 719 citations2009: 643 citations2010: 706 citations2011: 755 citations2012: 799 citations2013: 894 citations2014: 824 citations2015: 1,027 citations2016: 1,275 citations2017: 1,352 citations2018: 1,295 citations2019: 3,213 citations2020: 3,649 citations2021: 3,547 citations2022: 2,824 citations2023: 2,081 citations2024: 2,800 citations2025: 1,417 citations2026: 49 citations1906–1944: no citations, so these years are not shown1946–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 13,613 citing papers, 32.3% of this breakdownChina: 5,269 citing papers, 12.5% of this breakdownGermany: 2,426 citing papers, 5.8% of this breakdownUnited Kingdom: 2,296 citing papers, 5.4% of this breakdownFrance: 1,871 citing papers, 4.4% of this breakdownJapan: 1,672 citing papers, 4% of this breakdownItaly: 1,564 citing papers, 3.7% of this breakdownCanada: 1,187 citing papers, 2.8% of this breakdownAustralia: 1,140 citing papers, 2.7% of this breakdownSwitzerland: 928 citing papers, 2.2% of this breakdownNetherlands: 906 citing papers, 2.2% of this breakdownSpain: 814 citing papers, 1.9% of this breakdown
0%32.3%Other 20.1%

Institutions

Fields

  • Medicine42.8%
  • Immunology and Microbiology31.3%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Neuroscience2.2%
  • Engineering1.3%
  • Agricultural and Biological Sciences0.6%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers7.7%
  • Immunotherapy and Immune Responses7.6%
  • Immune Cell Function and Interaction7%
  • Immune cells in cancer3.5%
  • CAR-T cell therapy research3.3%
  • T-cell and B-cell Immunology3.3%
  • Other67.6%

Coauthors

All papers

Open in search
  1. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

    Authors: Chih‐Hao Chang, Jing Qiu, David O’Sullivan, Michael D. Buck, Takuro Noguchi, Jonathan D. Curtis, Qiongyu Chen, Mariel Gindin, Matthew M. Gubin, Gerritje J. W. van der Windt, Elena Tonc, Robert D. Schreiber, Edward J. Pearce, Erika L. Pearce, Erika L. Pearce, Erika L. Pearce - Cell 2015 cited by 3,311

  2. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

    Authors: Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth - Science 2011 cited by 6,463

  3. Neoantigens in cancer immunotherapy

    Authors: Ton N. Schumacher, Robert D. Schreiber - Science 2015 cited by 4,824

  4. Cancer immunoediting: from immunosurveillance to tumor escape

    Authors: Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda, Lloyd J. Old, Robert D. Schreiber - Nature Immunology 2002 cited by 5,284

  5. Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity

    Authors: Kai Hildner, Brian T. Edelson, Whitney E. Purtha, Mark S. Diamond, Hirokazu Matsushita, Masako Kohyama, Boris Calderón, Barbara U. Schraml, Emil R. Unanue, Michael Diamond, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy - Science 2008 cited by 2,055

  6. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

    Authors: Martina Molgora, Ekaterina Esaulova, William Vermi, Jinchao Hou, Yun Chen, Jingqin Luo, Simone Brioschi, Mattia Bugatti, Andrea Salvatore Omodei, Biancamaria Ricci, Catrina C. Fronick, Santosh K. Panda, Yoshiko Takeuchi, Matthew M. Gubin, Roberta Faccio, Marina Cella, Susan Gilfillan, Emil R. Unanue, Maxim N. Artyomov, Robert D. Schreiber, Marco Colonna - Cell 2020 cited by 664

  7. cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

    Authors: Stephen T. Ferris, Vivek Durai, Renee Wu, Derek J. Theisen, Jeffrey P. Ward, Michael D. Bern, Jesse T. Davidson, Prachi Bagadia, Tiantian Liu, Carlos G. Briseño, Lijin Li, William E. Gillanders, Gregory F. Wu, Wayne M. Yokoyama, Theresa L. Murphy, Robert D. Schreiber, Kenneth M. Murphy - Nature 2020 cited by 605

  8. MHC-II neoantigens shape tumour immunity and response to immunotherapy

    Authors: Elise Alspach, Danielle M. Lussier, Alexander P. Miceli, Ilya Kizhvatov, Michel DuPage, Adrienne Luoma, Wei Meng, Cheryl F. Lichti, Ekaterina Esaulova, Anthony N. Vomund, Daniele Runci, Jeffrey P. Ward, Matthew M. Gubin, Ruan F.V. Medrano, Cora D. Arthur, J. Michael White, Kathleen C. F. Sheehan, Alex Chen, Kai W. Wucherpfennig, Tyler Jacks, Emil R. Unanue, Maxim N. Artyomov, Robert D. Schreiber - Nature 2019 cited by 890

  9. The Three Es of Cancer Immunoediting

    Authors: Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber - Annual Review of Immunology 2004 cited by 3,016

  10. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Authors: Matthew M. Gubin, Xiuli Zhang, Heiko Schuster, Étienne Caron, Jeffrey P. Ward, Takuro Noguchi, Yulia Ivanova, Jasreet Hundal, Cora D. Arthur, Willem-Jan Krebber, Gwenn E. Mulder, Mireille Toebes, Matthew D. Vesely, Samuel S.K. Lam, Alan J. Korman, James P. Allison, Gordon J. Freeman, Arlene H. Sharpe, Erika L. Pearce, Ton N. Schumacher, Ruedi Aebersold, Hans-Georg Rammensee, Cornelis J.M. Melief, Elaine R. Mardis, William E. Gillanders, Maxim N. Artyomov, Robert D. Schreiber - Nature 2014 cited by 2,006

  11. The Immunobiology of Cancer Immunosurveillance and Immunoediting

    Authors: Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber - Immunity 2004 cited by 2,982

  12. Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity

    Authors: Elise Alspach, Danielle M. Lussier, Robert D. Schreiber - Cold Spring Harbor Perspectives in Biology 2018 cited by 566

  13. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Authors: Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David Enot, Julien Adam, Ilio Vitale, Aïcha Goubar, Elisa Elena Baracco, Catarina Remédios, Laetitia Fend, Dalil Hannani, Laetitia Aymeric, Yuting Ma, Mireia Niso‐Santano, Oliver Kepp, Joachim L. Schultze, Thomas Tüting, Filippo Belardelli, Laura Bracci, Valentina La Sorsa, Giovanna Ziccheddu, Paola Sestili, Francesca Urbani, Mauro Delorenzi, Magali Lacroix‐Triki, Virginie Quidville, Rosa Conforti, Jean-Philippe Spano, Lajos Pusztai, Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 cited by 1,031

  14. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

    Authors: Joshua D. Campbell, Anton Alexandrov, Jaegil Kim, Jeremiah A. Wala, Alice H. Berger, Chandra Sekhar Pedamallu, Sachet A. Shukla, Guangwu Guo, Angela N. Brooks, Bradley A. Murray, Marcin Imieliński, Xin Hu, Shiyun Ling, Rehan Akbani, Mara Rosenberg, Carrie Cibulskis, Aruna Ramachandran, Eric A Collisson, David J. Kwiatkowski, Michael S. Lawrence, John N. Weinstein, Roel G.W. Verhaak, Catherine J. Wu, Peter S. Hammerman, Andrew D. Cherniack, Gad Getz, Maxim N. Artyomov, Robert D. Schreiber, Ramaswamy Govindan, Matthew Meyerson - Nature Genetics 2016 cited by 1,234

  15. Type I interferon is selectively required by dendritic cells for immune rejection of tumors

    Authors: Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, Jessica M. Archambault, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber - The Journal of Experimental Medicine 2011 cited by 1,046

  16. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

    Authors: Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce, J. Michael White, Paul E. Swanson, Lloyd J. Old, Robert D. Schreiber - Nature 2001 cited by 2,814

  17. Natural Innate and Adaptive Immunity to Cancer

    Authors: Matthew D. Vesely, Michael H. Kershaw, Robert D. Schreiber, Mark J. Smyth - Annual Review of Immunology 2011 cited by 2,043

  18. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

    Authors: Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt, Charles G. Rickert, Ravindra Uppaluri, Vincent Magrini, Cora D. Arthur, J. Michael White, Yee-Shiuan Chen, Lauren Shea, Jasreet Hundal, Michael C. Wendl, Ryan Demeter, Todd Wylie, James P. Allison, Mark J. Smyth, Lloyd J. Old, Elaine R. Mardis, Robert D. Schreiber - Nature 2012 cited by 1,297

  19. New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

    Authors: Deepak Mittal, Matthew M. Gubin, Robert D. Schreiber, Mark J. Smyth - Current Opinion in Immunology 2014 cited by 1,452

  20. Interferons, immunity and cancer immunoediting

    Authors: Gavin P. Dunn, Catherine Koebel, Robert D. Schreiber - Nature reviews. Immunology 2006 cited by 1,615

  21. High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

    Authors: Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Olga Malkova, Daniele Runci, Pamela Wong, Takuro Noguchi, Cora D. Arthur, Wei Meng, Elise Alspach, Ruan F.V. Medrano, Catrina C. Fronick, Michael Fehlings, Evan W. Newell, Robert S. Fulton, Kathleen C. F. Sheehan, Stephen T. Oh, Robert D. Schreiber, Maxim N. Artyomov - Cell 2018 cited by 434

  22. Adaptive immunity maintains occult cancer in an equilibrium state

    Authors: Catherine Koebel, William Vermi, Jeremy B. Swann, Nadeen Zerafa, Scott J. Rodig, Lloyd J. Old, Mark J. Smyth, Robert D. Schreiber - Nature 2007 cited by 1,402

  23. WDFY4 is required for cross-presentation in response to viral and tumor antigens

    Authors: Derek J. Theisen, Jesse T. Davidson, Carlos G. Briseño, Marco Gargaro, Elvin J. Lauron, Qiuling Wang, Pritesh Desai, Vivek Durai, Prachi Bagadia, Joshua R. Brickner, Wandy L. Beatty, Herbert W. Virgin, William E. Gillanders, Nima Mosammaparast, Michael Diamond, L. David Sibley, Wayne M. Yokoyama, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy - Science 2018 cited by 339

  24. CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

    Authors: Mingyu He, Kate Roussak, Feiyang Ma, Nicholas Borcherding, Vince Garin, J. Michael White, Charles R. Schutt, Trine I. Jensen, Yun Zhao, Courtney A. Iberg, Kairav Shah, Himanshi Bhatia, Daniel Korenfeld, Sabrina Dinkel, Judah Gray, Alina Ulezko Antonova, Stephen T. Ferris, David L. Donermeyer, Cecilia S. Lindestam Arlehamn, Matthew M. Gubin, Jingqin Luo, Laurent Gorvel, Matteo Pellegrini, Alessandro Sette, Thomas Tung, Rasmus O. Bak, Robert L. Modlin, Ryan C. Fields, Robert D. Schreiber, Paul M. Allen, Eynav Klechevsky - Science 2023 cited by 112